Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical performance of non-invasive prenatal served as a first-tier screening test for trisomy 21, 18, 13 and sex chromosome aneuploidy in a pilot city in China

5 Jun 2020

Abstract excerpt

BACKGROUND: Cell-free fetal DNA (cffDNA) has opened up new approaches for non-invasive prenatal testing (NIPT), and it is often used as the second-tier test for high-risk pregnant women in detecting trisomy (T) 21, T18, and T13 after serum biochemistry screening. This study aims to discuss the clinical performance of NIPT as an alternative first-tier screening test for pregnant women in detecting T21, T18, T13,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Fetal and Pediatric Neurological Disorders
Share to Genomic variations and chromosomal abnormalities
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32503639
DOI: 10.1186/s40246-020-00268-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical performance of non-invasive prenatal served as a first-tier screening test for trisomy 21, 18, 13 and sex chromosome aneuploidy in a pilot city in ChinaPMID 32503639Read ↗

Non-invasive prenatal testing for the detection of trisomy 13, 18, and 21 and sex chromosome aneuploidies in 68,763 casesSemantic proximity Read ↗

Clinical performance of Non-invasive prenatal testing for sex chromosomal aneuploidies in Northeast ChinaSemantic proximity Read ↗

Non-invasive prenatal testing to detect chromosome aneuploidies in 57,204 pregnanciesSemantic proximity Read ↗

The Clinical Application of Non-invasive Prenatal Genetic Testing in the Screening of Fetal Chromosomal DiseasesSemantic proximity Read ↗

Clinical Application of Cell-Free DNA Sequencing-Based Noninvasive Prenatal Testing for Trisomies 21, 18, 13 and Sex Chromosome Aneuploidy in a Mixed-Risk Population in IranSemantic proximity Read ↗

Application of non-invasive prenatal testing for fetal chromosomal disorders in low-risk pregnancies: a follow-up study in central ChinaSemantic proximity Read ↗

Next-generation sequencing: a follow-up of 36,913 singleton pregnancies with noninvasive prenatal testing in central ChinaSemantic proximity Read ↗

A Retrospective Single-center Analysis of Prenatal Diagnosis and Follow-up of 626 Chinese Patients with Positive Non-invasive Prenatal Testing ResultsSemantic proximity Read ↗

Non‐invasive cell‐free fetal DNA testing for aneuploidy: multicenter study of 31 515 singleton pregnancies in southeastern ChinaSemantic proximity Read ↗

Performance analysis of non-invasive prenatal testing for trisomy 13, 18, and 21: A large-scale retrospective study (2018–2021)Semantic proximity Read ↗

Performance evaluation of noninvasive prenatal testing on 24 chromosomes in a cohort of 118,969 pregnant women in Sichuan, ChinaSemantic proximity Read ↗

Update on noninvasive prenatal testing: A review based on current worldwide researchSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.